G282-7201 Screening compound: N-CYCLOPENTYL-7-CYCLOPROPYL-6-METHYL-8-OXO-N-(2-PYRIDYLMETHYL)-5,6,7,8-TETRAHYDROIMIDAZO[1,5-A]PYRAZINE-1,6-DICARBOXAMIDE

G282-7201 Screening compound: N-CYCLOPENTYL-7-CYCLOPROPYL-6-METHYL-8-OXO-N-(2-PYRIDYLMETHYL)-5,6,7,8-TETRAHYDROIMIDAZO[1,5-A]PYRAZINE-1,6-DICARBOXAMIDE
G282-7201 Screening compound: N-CYCLOPENTYL-7-CYCLOPROPYL-6-METHYL-8-OXO-N-(2-PYRIDYLMETHYL)-5,6,7,8-TETRAHYDROIMIDAZO[1,5-A]PYRAZINE-1,6-DICARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound G282-7201
N-CYCLOPENTYL-7-CYCLOPROPYL-6-METHYL-8-OXO-N-(2-PYRIDYLMETHYL)-5,6,7,8-TETRAHYDROIMIDAZO[1,5-A]PYRAZINE-1,6-DICARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G282-7201

Molecular Formula

C23H28N6O3 (C23 H28 N6 O3)

Compound Name

N-CYCLOPENTYL-7-CYCLOPROPYL-6-METHYL-8-OXO-N-(2-PYRIDYLMETHYL)-5,6,7,8-TETRAHYDROIMIDAZO[1,5-A]PYRAZINE-1,6-DICARBOXAMIDE

IUPAC name

n/a

SMILES

CC(Cn1c2c(C(NCc3ncccc3)=O)nc1)(C(NC1CCCC1)=O)N(C1CC1)C2=O

InChI

InChI=1S/C23H28N6O3/c1-23(22(32)27-15-6-2-3-7-15)13-28-14-26-18(19(28)21(31)29(23)17-9-10-17)20(30)25-12-16-8-4-5-11-24-16/h4-5,8,11,14-15,17H,2-3,6-7,9-10,12-13H2,1H3,(H,25,30)(H,27,32)/t23-/m0/s1

InChI Key

WDMZXLNBLPQNGQ-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD27213198

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

436.51

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.069

Distribution Coefficient, logD

1.068

Water Solubility, LogSw

-2.00

Polar Surface Area

85.285

Acid Dissociation Constant (pKa)

12.79

Base Dissociation Constant (pKb)

4.27

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

52.20

G282-7201 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

Cyclic Ugi PPI Library (9586 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with G282-7201 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G282-7201?
Check Price and Availability of G282-7201, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G282-7201 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G282-7201
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G282-7201
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G282-7201 available by request